Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000172

Director sold 5,000 shares at an average $76.27 ($381,367)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PARSHALL B LYNNE Director 2026-04-15 Sale 10b5-1 −4,466 $76.19 $340,265 51,878 D: show line 1 in the form
PARSHALL B LYNNE Director 2026-04-15 Sale 10b5-1 −534 $76.97 $41,102 51,344 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $76.27 · $381,367
Loading xslF345X06/edgardoc.xml…